Aquatic Capital Management LLC Tarsus Pharmaceuticals, Inc. Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$25.17 - $38.73 $62,925 - $96,824
-2,500 Reduced 34.72%
4,700 $127,000
Q1 2024

May 15, 2024
BUY
$19.61 - $39.22 $49,025 - $98,050
2,500 Added 53.19%
7,200 $261,000
Q4 2023

Feb 14, 2024
BUY
$12.98 - $20.73 $61,006 - $97,431
4,700 New
4,700 $95,000
Q1 2023

May 15, 2023
BUY
$11.92 - $16.27 $4,768 - $6,508
400 New
400 $5,000

Others Institutions Holding TARS

# of Institutions
172
Shares Held
43.2M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.24B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email